Search Result "malignance-modulating."
Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 7 Year: 2016 Page: 777-787
Author(s): Malik Hamaidia,Bernard Staumont,Bernard Duysinx,Renaud Louis,Luc Willems
Novel Findings of Anti-cancer Property of Propofol
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2018 Page: 156-165
Author(s): Jiaqiang Wang,Chien-shan Cheng,Yan Lu,Xiaowei Ding,Minmin Zhu,Changhong Miao,Jiawei Chen
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and CisplatinResistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-cateninPathway and PI3K/AKT Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 11 Year: 2022 Page: 2098-2108
Author(s): Yuhang Quan,Shanshan Li,Yahong Wang,Guangshun Liu,Zhiyong Lv,Zhonghui Wang
The Role of Glioma Microenvironment in Immune Modulation: Potential Targets for Intervention
Journal: Letters in Drug Design & Discovery
Volume: 3 Issue: 7 Year: 2006 Page: 443-453
Author(s): Mahua Dey, S. Farzana Hussain, Amy B. Heimberger
Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies
Journal: Current Pharmaceutical Analysis
Volume: 7 Issue: 2 Year: 2011 Page: 120-124
Author(s): YI Sha, Chen Yan
The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 9 Year: 2007 Page: 877-887
Author(s): C. Ulivieri, C. T. Baldari
Global Gene Expression in Classification, Pathogenetic Understanding and Identification of Therapeutic Targets in Acute Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 8 Issue: 6 Year: 2007 Page: 344-354
Author(s): Anne Margrete Oyan, Trond Hellem Bo, Inge Jonassen, Elling Ulvestad, Bjorn Tore Gjertsen, Oystein Bruserud, Karl-Henning Kalland
Advances in Molecular Therapeutic Approaches to Patients with Malignant Gliomas
Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 1 Year: 2007 Page: 57-76
Author(s): Herbert B. Newton
Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2 Issue: 3 Year: 2002 Page: 387-401
Author(s): M. Tolomeo, D. Simoni
Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2051-2060
Author(s): M. P. Bernard, S. Bancos, P. J. Sime, R. P. Phipps